Artificial Intelligence in Medical Diagnostics segmentation by application delineates five principal domains: imaging, pathology, cardiology, genomics, and remote patient monitoring. Imaging AI tools—such as computer‑assisted detection in radiology—represent the largest share, accounting for roughly 35 % of market revenue, driven by high adoption in hospitals and the need for rapid image interpretation. Pathology AI, covering digital slide analysis and automated histopathology, contributes about 25 % as laboratories shift toward high‑throughput workflows. Cardiology AI, including arrhythmia detection and echocardiogram interpretation, holds 20 % of the market, reflecting integration with cardiac imaging suites and wearable ECG devices. Genomics AI, which accelerates variant calling and predictive modeling, captures 12 % of revenue, propelled by precision‑medicine initiatives. Finally, remote patient monitoring AI—encompassing symptom triage and tele‑diagnostic algorithms—accounts for the remaining 8 %, a segment expanding with telehealth adoption. Together, these application categories form the market taxonomy that defines the overall size of the Artificial Intelligence in Medical Diagnostics market.